In vitro tests to evaluate immunotoxicity: a preliminary study.

The implementation of Registration, Evaluation and Authorisation of new and existing Chemicals (REACH) will increase the number of laboratory animals used, if alternative methods will not be available. In the meantime, REACH promotes the use of in vitro tests and, therefore, a set of appropriated alternative testing methods and assessment strategies are needed. The immune system can be a target for many chemicals including environmental contaminants and drugs with potential adverse effects on human health. The aim of this study was to evaluate the predictivity of a set of in vitro assays to detect immunosuppression. The tests have been performed on human, rat and murine cells. Different endpoints have been assessed: cytotoxicity, cytokine release, myelotoxicity and mitogen responsiveness. For each of these endpoints IC50s values have been calculated. Six chemical substances, representative of the full range of in vivo responses and for which good human and/or animal data are available either from databases or literature, have been selected: two chemicals classified as not immunotoxic (Urethane and Furosemide), and four (tributyltin chloride (TBTC), Verapamil, Cyclosporin A, Benzo(a)pyrene) with different effect on immune system. All the tests confirmed the strong immunotoxic effect of TBTC as well as they confirmed the negative controls. For one chemical (Verapamil) the IC50 is similar through the different tests. The IC50s obtained with the other chemicals depend on the endpoints and on the animal species. The clonogenic test (CFU-GM) and the mitogen responsiveness showed similar IC50s between human and rodent cells except for Cyclosporin A and TBTC. All different tests classified the compounds analyzed in the same way.

[1]  W. Jusko,et al.  Immunosuppressive interactions among calcium channel antagonists and selected corticosteroids and macrolides using human whole blood lymphocytes. , 2004, Drug metabolism and pharmacokinetics.

[2]  A. N. Tucker,et al.  Acute myelotoxic responses in mice exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). , 1985, Toxicology and applied pharmacology.

[3]  D. Snodin.  Regulatory immunotoxicology: does the published evidence support mandatory nonclinical immune function screening in drug development? , 2004, Regulatory toxicology and pharmacology : RTP.

[4]  D. Parent-Massin,et al.  Prevalidation of a model for predicting acute neutropenia by colony forming unit granulocyte/macrophage (CFU-GM) assay. , 2001, Toxicology in vitro : an international journal published in association with BIBRA.

[5]  Aldert Piersma,et al.  The ECVAM International Validation Study on In Vitro Embryotoxicity Tests: Results of the Definitive Phase and Evaluation of Prediction Models , 2002, Alternatives to laboratory animals : ATLA.

[6]  R. Pieters,et al.  The Use of In Vitro Systems for Evaluating Immunotoxicity: The Report and Recommendations of an ECVAM Workshop , 2005, Journal of immunotoxicology.

[7]  C. Janeway.  Immunobiology: The Immune System in Health and Disease , 1996 .

[8]  Co Denver,et al.  HSDB. Hazardous Substances Data Bank : National Library of Medicine, Micromedx,Inc. , 1995 .

[9]  Y. Sugita‐Konishi,et al.  Effect of Lactational Exposure to Tributyltin Chloride on Innate Immunodefenses in the F1 Generation in Mice , 2005, Bioscience, biotechnology, and biochemistry.

[10]  T. Hartung,et al.  Whole blood cytokine response as a measure of immunotoxicity. , 2001, Toxicology in vitro : an international journal published in association with BIBRA.

[11]  R. Lochmiller,et al.  Evaluation Of Myelotoxicity In Cotton Rats (Sigmodon hispidus) Exposed To Environmental Contaminants. I. In Vitro Bone-Marrow Progenitor Culture , 2001, Journal of toxicology and environmental health. Part A.

[12]  Leszek Rychlewski,et al.  Fluorescent Cell Chip a new in vitro approach for immunotoxicity screening. , 2006, Toxicology letters.

[13]  N. Sigal,et al.  Is cyclophilin involved in the immunosuppressive and nephrotoxic mechanism of action of cyclosporin A? , 1991, The Journal of experimental medicine.

[14]  Valérie Zuang,et al.  A Modular Approach to the ECVAM Principles on Test Validity , 2004, Alternatives to laboratory animals : ATLA.

[15]  D. Birx,et al.  The interference of T cell activation by calcium channel blocking agents. , 1984, Journal of immunology.

[16]  R. Lochmiller,et al.  Evaluation of Myelotoxicity in Cotton Rats (Sigmodon hispidus) Exposed To Environmental Contaminants. II. Myelotoxicity Associated with Petroleum Industrial Wastes , 2001, Journal of toxicology and environmental health. Part A.

[17]  L. Reed,et al.  A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS , 1938 .

[18]  J. Dean.  Issues with introducing new immunotoxicology methods into the safety assessment of pharmaceuticals. , 1997, Toxicology.

[19]  H. Kirchner,et al.  A whole-blood technique for testing production of human interferon by leukocytes. , 1982, Journal of immunological methods.

[20]  H. Lebrec,et al.  Immunotoxicological investigation using pharmaceutical drugs. In vitro evaluation of immune effects using rodent or human immune cells. , 1995, Toxicology.

[21]  W. Seinen,et al.  Biological activity of organotin compounds--an overview. , 1987, Environmental research.

[22]  D Parent-Massin,et al.  Application of the CFU-GM assay to predict acute drug-induced neutropenia: an international blind trial to validate a prediction model for the maximum tolerated dose (MTD) of myelosuppressive xenobiotics. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.